Accuray's (ARAY) Radixact for Cancer Treatment Debuts in US
Accuray's (ARAY) Radixact System with VitalHold technology is set to enhance precision and comfort in radiation therapy.
Accuray (ARAY) Q4 Earnings Lag Estimates, Gross Margin Shrinks
Despite improving product sales, Accuray (ARAY) reports mixed fourth-quarter fiscal 2024 results.
Accuray Incorporated (ARAY) Q4 2024 Earnings Call Transcript
Accuray Incorporated (NASDAQ:ARAY ) Q4 2024 Earnings Call Transcript August 14, 2024 4:30 PM ET Company Participants Jesse Chew - SVP and Chief Legal Officer Suzanne Winter - President and CEO Ali Pervaiz - CFO Conference Call Participants Young Li - Jefferies Marie Thibault - BTIG Brooks O'Neil - Lake Street Capital Markets Jason Wittes - Roth Capital Operator Good day, and welcome to the Accuray Fscal 2024 Fourth Quarter Financial Results Call. All participants will be in listen-only mode.
Here's Why You Should Retain Accuray (ARAY) Stock for Now
Accuray's (ARAY) solid product demand raises optimism about the stock.
3 Penny Stock Lotto Tickets With 100X Potential
When it comes to investing in top penny stocks, a word of caution. Always do your due diligence before buying.
Accuray (ARAY), TrueNorth Unite to Aid Radiation Departments
Accuray (ARAY) announces an agreement with TrueNorth to provide radiation oncology departments with third-party support designed to improve their department's capabilities.
Accuray's (ARAY) Precision TPS Gets Approved by China's NMPA
Accuray (ARAY) announces the approval of the Accuray Precision Treatment Planning System by the Chinese Medical Products Administration.
Accuray (ARAY) Up 2% Since Last Earnings Report: Can It Continue?
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?
New Strong Sell Stocks for May 31st
ASGN, ARAY and BGS have been added to the Zacks Rank #5 (Strong Sell) List on May 31, 2023.
New Strong Sell Stocks for May 24th
DDD, ARAY and BNTGY have been added to the Zacks Rank #5 (Strong Sell) List on May 24, 2023.
